Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01
December 06, 2023 07:00 ET
|
Ractigen Therapeutics
This milestone marks Ractigen's transition into clinical development, with RAG-01 targeting NMIBC.
Global Gene Therapy Research Report 2023-2028: Increasing Regulatory Approvals, Growing Investments, Rising Demand for Cell & Gene Therapies
November 17, 2023 09:13 ET
|
Research and Markets
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area...
Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
November 02, 2023 08:00 ET
|
Ractigen Therapeutics
Ractigen Presents Preclinical Results of Its saRNA Therapeutic Targeting DMD/BMD at the Oligonucleotide Therapeutics Society (OTS) Annual Meeting
Global Gene Therapy Market Poised for Remarkable 9.26% CAGR, Expected to Reach USD 10.13 Billion by 2028
October 31, 2023 08:48 ET
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
DNA Encoded Library Market Set to Reach $840 Million in 2023, Driven by Transformative Impact on Drug Discovery
October 17, 2023 07:53 ET
|
Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "DNA Encoded Library: Platforms and Services Market (2nd Edition), 2023-2035" report has been added to ResearchAndMarkets.com's offering. The global...
Advancing Beyond Antibody Drug Conjugates: Next Generation Drug Conjugates Emerge as Clinical Efficacy and Stability Game Changers
October 12, 2023 05:38 ET
|
Research and Markets
Dublin, Oct. 12, 2023 (GLOBE NEWSWIRE) -- The "Next Generation Drug Conjugates Market: Distribution by Type of Targeting Ligand, Type of Payload, Type of Therapy, Route of Administration, Target...
Global Oligonucleotide Synthesis Markets Research Report 2023 With Executive and Consultant Guides & Forecasts to 20277
October 05, 2023 06:38 ET
|
Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027" report...
Government Funding Propels Global Synthetic Biology Market, Valued at $11.24 Billion in 2022
October 05, 2023 04:18 ET
|
Research and Markets
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market by Product, Application, Technology, End User, and by Region - Global Forecast to 2023-2033" report has been added to ...
Dyadic and bYoRNA Announce a Collaboration Targeting the Production of Abundant, Low-Cost mRNA From C1-Cells
September 26, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and PARIS, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI) and bYoRNA SAS ("bYoRNA") today announced that they entered into a development and...
RNA Therapy Clinical Trials Market Report 2023-2030: Strategies and Collaborations Shaping the Industry
August 29, 2023 04:48 ET
|
Research and Markets
Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "RNA Therapy Clinical Trials Market Size, Share & Trends Analysis Report, 2023-2030" report has been added to ResearchAndMarkets.com's offering. ...